// App-Quantinova.ai

: Identification of Risk Factors for and Development of a Predictive Model for Immunotherapy-Associated Venous Thromboembolism (VTE) in Patients with Non-Small Cell Lung Cancer

Researchers

Presenter

  • Kristen M. Sanfilippo

Principal Investigators

  • Suhong Luo

  • Gary H. Lyman

  • David C. Calverley

  • Nicole M.M. Kuderer

Medical Centers

  • Portland VA Medical Center, Portland, OR

  • Fred Hutchinson Cancer Research Center, SEATTLE, WA

  • Advanced Cancer Research Group, Seattle, WA

  • St. Louis VA Medical Center Research Service, St. Louis, MO

  • Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, WA

  • Division of Medical Oncology, University of British Columbia, BC Cancer Agency, Vancouver, Canada

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Non Small Cell Lung cancer

  • Venous thrombosis

  • Lung Cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Aspirin

  • Albyl-E

Outcome

  • N/A


Study Design

  • Observational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A